Personal Health

Drug therapy in Parkinson’s disease

Walk, talk, write, grab, eat, or laugh – all of this requires the ability to can in a targeted and controlled move. For people who suffer from Parkinson’s disease, such things are not a matter of course. What are the therapy options available to you, what can expect the patient from the medication, and where their limits lay, and neurologists to inform on the occasion of world Parkinson’s day on Thursday, 11. In April 2019, on free reader phone.

Call!

Thursday, 11. April 2019 10 to 14 at 0800 – 5 33 22 11

The call is out to all German networks free of charge.

Parkinson’s disease is caused by a lack of dopamine, a neurotransmitter that is involved in the brain instrumental in the control of body movements. The consequences are a movement disorders, uncontrollable Shaking, muscle stiffness and impaired balance. Since a cure is not possible today, the treatment on the control of the symptoms. The primary goal of this work is the lack of Dopamine in the brain to balance, to improve mobility and control of movement.

A number of well-studied and effective drugs available that act in different ways on the dopamine household in the brain. Nevertheless, finding the right treatment, patients and Doctors face many great challenges. Because the symptoms of the Patient different to the Patient, and the efficacy and tolerability of the drugs. In addition, the disease in spite of medication progresses, and a frequent adjustment of the medication requires.

When and how often should I check my medication and adjust? Someday, I’m "austherapiert"? What are the Alternatives to my currently prescribed medications? How can interactions with other drugs? All questions relating to the treatment of Parkinson’s answer experienced neurologists and experts at the on Thursday, 11. In April 2019, on free reader phone.

On the phone 0800 – 5 33 22 11

  • Prof. Dr. med. Candan Depboylu specialist in neurology, has additional qualifications in Special Neurological intensive care medicine, neuro-geriatrics and Somnology (DGSM), chief physician of the Neurological clinic Sorpesee, Sundern
  • Prof. Dr. med. Michael barbelspecialist physician for neurology, head of the Cologne-based Parkinson’s network, a senior physician at the clinic and polyclinic for neurology, University hospital Cologne
  • Prof. Dr. med. Rüdiger Hilker-rye village isa specialist in neurology, Neurological intensive care medicine, chief physician of the clinic for neurology and Clinical neurophysiology, Klinikum Vest
  • Prof. Dr. med. Dirk Woitallaspecialist physician for neurology, head physician of the clinic for neurology, St. Josef-Krankenhaus Kupferdreh Essen

NK